Vimarsana
Biggest News Aggregation in the World

Page 6 - Adaptive Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adaptive Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adaptive Research Today - Breaking & Trending Today

Kintara Therapeutics Announces Fiscal 2023 Third Quarter Financial Results and Provides Corporate Update - Vimarsana News

Kintara Therapeutics Announces Fiscal 2023 Third Quarter Financial Results and Provides Corporate Update

/PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid...

Kintara Therapeutics to Present at the Sidoti Micro-Cap Virtual Conference - Vimarsana News

Kintara Therapeutics to Present at the Sidoti Micro-Cap Virtual Conference

SAN DIEGO, May 8, 2023 /PRNewswire/ --  Kintara Therapeutics, Inc.  , a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that its... | May 8, 2023

Kintara Therapeutics to Present at the Aegis Capital Virtual Conference - Vimarsana News

Kintara Therapeutics to Present at the Aegis Capital Virtual Conference

SAN DIEGO, May 1, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc.  , a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that its... | May 1, 2023

Kintara Therapeutics Announces Data Presentation at the 2023 American Association for Cancer Research Annual Meeting - Vimarsana News

Kintara Therapeutics Announces Data Presentation at the 2023 American Association for Cancer Research Annual Meeting

/PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid...

Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA - Vimarsana News

Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial | Critical Care Medicine | JAMA

This randomized clinical trial examines the effect of initiation of a renin-angiotensin system inhibitor (ACE inhibitor or an angiotensin receptor blocker) on t